HER2-positivity rates in advanced gastric cancer (GC): Results from a large international phase III trial

被引：9

作者：

Bang, Y.

Chung, H.

Sawaki, A.

Xu, J.

Shen, L.

Lipatov, O.

Park, S. R.

Gangadharan, V. P.

Advani, S. H.

Kang, Y. K.

机构：

[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea

[2] Yonsei Univ, Coll Med, Seoul, South Korea

[3] Aichi Canc Ctr, Nagoya, Aichi 464, Japan

[4] Affiliated Hosp 307 Hosp, Ctr Canc, Beijing, Peoples R China

[5] Beijing Canc Hosp, Beijing, Peoples R China

[6] Natl Canc Ctr, Goyang, South Korea

[7] Lakeshore Hosp & Res Ctr Ltd, Kochi, India

[8] Jaslok Hosp & Res Ctr, Bombay, Maharashtra, India

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.4526

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4526

引用

页数：1